Humanized Anti-hepatocyte Growth Factor Monoclonal Antibody (YYB-101) Inhibits Ovarian Cancer Progression

por Kim, Hyun Jung, Lee, Sukmook, Oh, Yong-Seok, Chang, Ha Kyun, Kim, Young Sang, Hong, Sung Hee, Kim, Jung Yong, Park, Young-Whan, Lee, Song-Jae, Song, Seong-Won, Kim, Jung Ju, Heo, Kyun
Publicado 2019

A Fully-Human Antibody Specifically Targeting a Membrane-Bound Fragment of CADM1 Potentiates the T Cell-Mediated Death of Human Small-Cell Lung Cancer Cells

por Lee, Ji Hyun, Kim, Ji Woong, Yang, Ha Rim, Song, Seong-Won, Lee, Song-Jae, Jeon, Yeongha, Ju, Anna, Lee, Narim, Kim, Min-Gu, Kim, Minjoo, Hwang, Kyusang, Yoon, Jin Hwan, Shim, Hyunbo, Lee, Sukmook
Publicado 2022

Preclinical development of a humanized neutralizing antibody targeting HGF

por Kim, Hyori, Hong, Sung Hee, Kim, Jung Yong, Kim, In-Chull, Park, Young-Whan, Lee, Song-Jae, Song, Seong-Won, Kim, Jung Ju, Park, Gunwoo, Kim, Tae Min, Kim, Yun-Hee, Park, Jong Bae, Chung, Junho, Kim, In-Hoo
Publicado 2017

Chimeric Antigen Receptor T Cells With Modified Interleukin-13 Preferentially Recognize IL13Rα2 and Suppress Malignant Glioma: A Preclinical Study

por Kim, Kiwan, Gwak, Ho-Shin, Han, Nayoung, Hong, Eun Kyung, Choi, Beom K., Lee, Sangeun, Choi, Soyoung, Park, Ju-Hwang, Seok, Ji-Hye, Jeon, Yeongha, Cho, Hyuntae, Lee, Song-Jae, Lee, Yura, Nam, Ki Taek, Song, Seong-Won
Publicado 2021

First-in-human phase I trial of anti-hepatocyte growth factor antibody (YYB101) in refractory solid tumor patients

por Kim, Seung Tae, Hong, Jung Yong, Park, Se Hoon, Park, Joon Oh, Park, Young Whan, Park, Neunggyu, Lee, Hukeun, Hong, Sung Hee, Lee, Song-Jae, Song, Seong-Won, Kim, Kyung, Park, Young Suk, Lim, Ho Yeong, Kang, Won Ki, Nam, Do-Hyun, Lee, Jeong-Won, Park, Keunchil, Kim, Kyoung-Mee, Lee, Jeeyun
Publicado 2020